{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:47:05Z","timestamp":1789660025479,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T00:00:00Z","timestamp":1276732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00702-010-0434-3","type":"journal-article","created":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T15:51:02Z","timestamp":1276703462000},"page":"361-369","source":"Crossref","is-referenced-by-count":63,"title":["Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"118","author":[{"given":"Zhanyun","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,17]]},"reference":[{"key":"434_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0730-725X(98)00155-6","volume":"17","author":"G Bartzokis","year":"1999","unstructured":"Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas TA, Tishler TA, Marder SR, Mintz J (1999) MRI evaluation of brain iron in earlier- and later-onset Parkinson\u2019s disease and normal subjects. Magn Reson Imaging 17:213\u2013222","journal-title":"Magn Reson Imaging"},{"key":"434_CR2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.45.1.182","volume":"45","author":"G Becker","year":"1995","unstructured":"Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson\u2019s disease visualized by transcranial color-coded real-time sonography. Neurology 45:182\u2013184","journal-title":"Neurology"},{"key":"434_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1212\/WNL.56.1.13","volume":"56","author":"D Berg","year":"2001","unstructured":"Berg D, Siefker C, Ruprecht-D\u00f6rfler P, Becker G (2001) Echo pattern of substantia nigra and its relevance for motor function and motility in elderly subjects. Neurology 56:13\u201317","journal-title":"Neurology"},{"key":"434_CR4","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K (2008) Invited Article: nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925","journal-title":"Neurology"},{"key":"434_CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004010000247","volume":"101","author":"E Braak","year":"2001","unstructured":"Braak E, Sandmann-Keil D, Rub U et al (2001) Alpha-synuclein immunopositive Parkinson\u2019s disease-related inclusion bodies in lower brain stem nuclei. Acta Neuropathol 101:195\u2013201","journal-title":"Acta Neuropathol"},{"key":"434_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"434_CR7","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1074\/jbc.M409946200","volume":"280","author":"NB Cole","year":"2005","unstructured":"Cole NB, Murphy DD, Lebowitz J, Di Noto L, Levine RL, Nussbaum RL (2005) Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. J Biol Chem 280:9678\u20139690","journal-title":"J Biol Chem"},{"key":"434_CR8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4:1318\u20131320","journal-title":"Nat Med"},{"key":"434_CR9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb06903.x","volume":"920","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, Williamson RE, Lansbury PT Jr (2000) Accelerated oligomerization by Parkinson\u2019s disease linked alpha-synuclein mutants. Ann N Y Acad Sci 920:42\u201345","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 8","key":"434_CR10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain 122(Pt 8):1437\u20131448","journal-title":"Brain"},{"key":"434_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000046872","volume":"10","author":"M Ebadi","year":"2001","unstructured":"Ebadi M (2001) Introduction. Oxidative stress in mitochondria disorders of aging. Biol Signals Recept 10:5\u201313","journal-title":"Biol Signals Recept"},{"key":"434_CR12","first-page":"217","volume":"69","author":"LS Forno","year":"1996","unstructured":"Forno LS, DeLanney LE, Irwin I, Langston JW (1996) Electron microscopy of Lewy bodies in the amygdala-parahippocampal region: comparison with inclusion bodies in the MPTP-treated squirrel monkey. Adv Neurol 69:217\u2013228","journal-title":"Adv Neurol"},{"key":"434_CR13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.mp.4001937","volume":"12","author":"AL Friedlich","year":"2007","unstructured":"Friedlich AL, Tanzi RE, Rogers JT (2007) The 5\u2032-untranslated region of Parkinson\u2019s disease alpha-synuclein messengerRNA contains a predicted iron responsive element. Mol Psychiatry 12:222\u2013223","journal-title":"Mol Psychiatry"},{"key":"434_CR15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410260403","volume":"26","author":"DC German","year":"1989","unstructured":"German DC, Manaye K, Smith WK, Woodward DJ, Saper CB (1989) Midbrain dopaminergic cell loss in Parkinson\u2019s disease: computer visualization. Ann Neurol 26:507\u2013514","journal-title":"Ann Neurol"},{"key":"434_CR16","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","volume":"274","author":"BI Giasson","year":"1999","unstructured":"Giasson BI, Uryu K, Trojanowski JQ, Lee VM (1999) Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274:7619\u20137622","journal-title":"J Biol Chem"},{"key":"434_CR17","doi-asserted-by":"crossref","first-page":"16116","DOI":"10.1074\/jbc.M107866200","volume":"277","author":"N Golts","year":"2002","unstructured":"Golts N, Snyder H, Frasier M, Theisler C, Choi P, Wolozin B (2002) Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. J Biol Chem 277:16116\u201316123","journal-title":"J Biol Chem"},{"key":"434_CR18","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.45.6.1138","volume":"45","author":"JM Gorell","year":"1995","unstructured":"Gorell JM, Ordidge RJ, Brown GG, Deniau JC, Buderer NM, Helpern JA (1995) Increased iron-related MRI contrast in the substantia nigra in Parkinson\u2019s disease. Neurology 45:1138\u20131143","journal-title":"Neurology"},{"key":"434_CR19","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0306-4522(02)00385-8","volume":"115","author":"RJ Grant","year":"2002","unstructured":"Grant RJ, Clarke PB (2002) Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia. Neuroscience 115:1281\u20131294","journal-title":"Neuroscience"},{"key":"434_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-8993(98)00514-9","volume":"799","author":"M Hashimoto","year":"1998","unstructured":"Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, Sundsmo M, Masliah E (1998) Human recombinant NACP\/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res 799:301\u2013306","journal-title":"Brain Res"},{"key":"434_CR21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-8993(96)00313-7","volume":"735","author":"Y He","year":"1996","unstructured":"He Y, Thong PS, Lee T, Leong SK, Shi CY, Wong PT, Yuan SY, Watt F (1996) Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study. Brain Res 735:149\u2013153","journal-title":"Brain Res"},{"key":"434_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/10715769900301611","volume":"31","author":"Y He","year":"1999","unstructured":"He Y, Lee T, Leong SK (1999) Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning. Free Radic Res 31:103\u2013112","journal-title":"Free Radic Res"},{"key":"434_CR23","first-page":"14","volume":"41","author":"HC Hung","year":"1996","unstructured":"Hung HC, Lee EH (1996) The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP\u00a0+\u00a0toxicity: role of BDNF gene expression. Brain Res Mol Brain Res 41:14\u201326","journal-title":"Brain Res Mol Brain Res"},{"key":"434_CR24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0891-5849(97)00206-2","volume":"24","author":"HC Hung","year":"1998","unstructured":"Hung HC, Lee EH (1998) MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic Biol Med 24:76\u201384","journal-title":"Free Radic Biol Med"},{"key":"434_CR25","first-page":"267","volume":"60","author":"KA Jellinger","year":"1993","unstructured":"Jellinger KA, Kienzl E, Rumpelmaier G, Paulus W, Riederer P, Stachelberger H, Youdim MB, Ben-Shachar D (1993) Iron and ferritin in substantia nigra in Parkinson\u2019s disease. Adv Neurol 60:267\u2013272","journal-title":"Adv Neurol"},{"key":"434_CR26","first-page":"571","volume":"55","author":"H Jiang","year":"2003","unstructured":"Jiang H, Qian ZM, Xie JX (2003) Increased DMT1 expression and iron content in MPTP-treated C57BL\/6 mice. Sheng Li Xue Bao 55:571\u2013576","journal-title":"Sheng Li Xue Bao"},{"key":"434_CR27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuint.2006.04.015","volume":"49","author":"H Jiang","year":"2006","unstructured":"Jiang H, Luan Z, Wang J, Xie J (2006) Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 49:605\u2013609","journal-title":"Neurochem Int"},{"key":"434_CR28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/cr.2010.20","volume":"20","author":"H Jiang","year":"2010","unstructured":"Jiang H, Song N, Xu H, Zhang S, Wang J, Xie J (2010) Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE\/IRP dependent. Cell Res 20:345\u2013356","journal-title":"Cell Res"},{"key":"434_CR29","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1074\/jbc.M709634200","volume":"283","author":"M Kostka","year":"2008","unstructured":"Kostka M, Hogen T, Danzer KM et al (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem 283:10992\u201311003","journal-title":"J Biol Chem"},{"key":"434_CR30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.nbd.2006.04.007","volume":"23","author":"M Maingay","year":"2006","unstructured":"Maingay M, Romero-Ramos M, Carta M, Kirik D (2006) Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiol Dis 23:522\u2013532","journal-title":"Neurobiol Dis"},{"key":"434_CR31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","volume":"56","author":"KS McNaught","year":"2004","unstructured":"McNaught KS, Perl DP, Brownell AL, Olanow CW (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson\u2019s disease. Ann Neurol 56:149\u2013162","journal-title":"Ann Neurol"},{"key":"434_CR32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","volume":"956","author":"GE Meredith","year":"2002","unstructured":"Meredith GE, Totterdell S, Petroske E, Santa Cruz K, Callison RC Jr, Lau YS (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson\u2019s disease. Brain Res 956:156\u2013165","journal-title":"Brain Res"},{"key":"434_CR33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(94)90462-6","volume":"168","author":"H Mochizuki","year":"1994","unstructured":"Mochizuki H, Imai H, Endo K, Yokomizo K, Murata Y, Hattori N, Mizuno Y (1994) Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Neurosci Lett 168:251\u2013253","journal-title":"Neurosci Lett"},{"key":"434_CR34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.ne.01.030178.001021","volume":"1","author":"RY Moore","year":"1978","unstructured":"Moore RY, Bloom FE (1978) Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu Rev Neurosci 1:129\u2013169","journal-title":"Annu Rev Neurosci"},{"key":"434_CR35","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000","volume":"20","author":"N Ostrerova-Golts","year":"2000","unstructured":"Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B (2000) The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 20:6048\u20136054","journal-title":"J Neurosci"},{"key":"434_CR36","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1523\/JNEUROSCI.1569-07.2007","volume":"27","author":"J Peng","year":"2007","unstructured":"Peng J, Peng L, Stevenson FF, Doctrow SR, Andersen JK (2007) Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson\u2019s disease accelerate age-related neurodegeneration. J Neurosci 27:6914\u20136922","journal-title":"J Neurosci"},{"key":"434_CR37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","volume":"106","author":"E Petroske","year":"2001","unstructured":"Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS (2001) Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment. Neuroscience 106:589\u2013601","journal-title":"Neuroscience"},{"key":"434_CR39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archneur.1995.00540300057013","volume":"52","author":"P Ryvlin","year":"1995","unstructured":"Ryvlin P, Broussolle E, Piollet H, Viallet F, Khafallah Y, Chazot G (1995) Magnetic resonance imaging evidence of decreased putaminal iron content in idiopathic Parkinson\u2019s disease. Arch Neurol 52:583\u2013588","journal-title":"Arch Neurol"},{"key":"434_CR40","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","volume":"105","author":"J Salazar","year":"2008","unstructured":"Salazar J, Mena N, Hunot S, Prigent A et al (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson\u2019s disease. Proc Natl Acad Sci USA 105:18578\u201318583","journal-title":"Proc Natl Acad Sci USA"},{"key":"434_CR41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-4159.1991.tb02017.x","volume":"56","author":"E Sofic","year":"1991","unstructured":"Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56:978\u2013982","journal-title":"J Neurochem"},{"key":"434_CR42","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/jnr.21430","volume":"85","author":"N Song","year":"2007","unstructured":"Song N, Jiang H, Wang J, Xie JX (2007) Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. J Neurosci Res 85:3118\u20133126","journal-title":"J Neurosci Res"},{"key":"434_CR43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(90)91656-2","volume":"528","author":"E Sundstrom","year":"1990","unstructured":"Sundstrom E, Fredriksson A, Archer T (1990) Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL\/6 mice: a model for Parkinson\u2019s disease. Brain Res 528:181\u2013188","journal-title":"Brain Res"},{"key":"434_CR44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1471-4159.1994.62010134.x","volume":"62","author":"JA Temlett","year":"1994","unstructured":"Temlett JA, Landsberg JP, Watt F, Grime GW (1994) Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis. J Neurochem 62:134\u2013146","journal-title":"J Neurochem"},{"key":"434_CR45","first-page":"422","volume":"55","author":"J Wang","year":"2003","unstructured":"Wang J, Jiang H, Xie JX (2003) Correlation between iron levels and degeneration of dopaminergic neurons in rat nigrostriatal system during the early 6-OHDA lesions in medial forebrain bundle. Sheng Li Xue Bao 55:422\u2013427","journal-title":"Sheng Li Xue Bao"},{"key":"434_CR46","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuint.2005.02.008","volume":"47","author":"J Wang","year":"2005","unstructured":"Wang J, Qian ZM, Jiang H, Xie J, Ke Y (2005) Treatment with nerve growth factor decreases expression of divalent metal transporter 1 and transferrin receptor in PC12 cells. Neurochem Int 47:514\u2013517","journal-title":"Neurochem Int"},{"key":"434_CR47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuint.2008.10.003","volume":"54","author":"J Wang","year":"2009","unstructured":"Wang J, Xu HM, Yang HD, Du XX, Jiang H, Xie JX (2009) Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochem Int 54:43\u201348","journal-title":"Neurochem Int"},{"key":"434_CR48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0306-4522(87)90178-3","volume":"23","author":"CM Waters","year":"1987","unstructured":"Waters CM, Hunt SP, Jenner P, Marsden CD (1987) An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset. Neuroscience 23:1025\u20131039","journal-title":"Neuroscience"},{"key":"434_CR49","unstructured":"Xu H, Jiang H, Wang J, Xie J (2010) Rg1 protects the MPP(+)-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake. Neuropharmacology 58(2):488\u2013494"},{"key":"434_CR50","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2007.11.025","volume":"30","author":"S Zhang","year":"2009","unstructured":"Zhang S, Wang J, Song N, Xie J, Jiang H (2009) Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Neurobiol Aging 30:1466\u20131476","journal-title":"Neurobiol Aging"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0434-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-010-0434-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0434-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T20:58:41Z","timestamp":1591390721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-010-0434-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,17]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1007\/s00702-010-0434-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,17]]}}}